World Journal of Gastrointestinal Surgery - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (651)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

495

Sum=516

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=106

Nov 27, 2024 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Christodoulidis G, Bartzi D, Koumarelas KE, Kouliou MN. Pembrolizumab in patients with gastric cancer and liver metastases: A paradigm shift in immunotherapy. World J Gastrointest Surg 2024; 16(11): 3391-3394 [PMID: PMC11622097 DOI: 10.4240/wjgs.v16.i11.3391]
URL:	https://www.wjgnet.com/1948-9366/full/v16/i11/3391.htm

Number	Citing Articles
1	Xue-Mei Yi, Hong-Qiao Cai, Yan Jiao. Programmed cell death receptor 1 inhibitor Pembrolizumab in the treatment of advanced gastric cancer. World Journal of Gastrointestinal Surgery 2025; 17(2): 100257 doi: 10.4240/wjgs.v17.i2.100257 Abstract(58) \| Core Tip(65) \| Full Article(HTML)(90) \| Full Article with Cover (PDF)-719K(12) \| Audio-812K(9) \| Peer-Review Report-447K(11) \| Answering Reviewers-64K(8) \| Full Article (PDF)-358K(13) \| Full Article (XML)-64K(9) \| Times Cited (0) \| Total Visits (497) \| Open

Number

Citing Articles

Xue-Mei Yi, Hong-Qiao Cai, Yan Jiao. Programmed cell death receptor 1 inhibitor Pembrolizumab in the treatment of advanced gastric cancer. World Journal of Gastrointestinal Surgery 2025; 17(2): 100257 doi: 10.4240/wjgs.v17.i2.100257